The Department of Health, in its UK Antimicrobial Resistance Strategy, has called for more research into drug resistant infections also known as antimicrobial resistance (AMR). The National Institute for Health Research (NIHR), the research arm of the NHS, has responded to this call by funding 16 studies, an investment of over £15.8 million to date, with funding of further projects expected during 2015.
Professor Dame Sally C. Davies, Chief Medical Officer and Chief Scientific Adviser at the Department of Health said:
“Antimicrobial resistance is a very serious problem for society causing 5,000 deaths in the UK each year. We will lose this battle unless we get more evidence on how to prevent resistance in bacteria developing. That is why the research that the NIHR has committed to funding is so vital. This will help us stop current everyday health problems becoming fatal.”
Further information is available here
The NIHR HTA Programme is pleased to announce that Professor Julia Brown, Director of the Clinical Trials Unit at the University of Leeds has been appointed as Deputy Chair of the HTA Clinical Evaluation and Trials board.
Infections are the most common reason for care home residents to be hospitalised, and previous research shows care home residents are the biggest user group for antibiotics, which puts them at significant risk of developing antibiotic drug resistance.
Surrey and Borders Partnership NHS Foundation Trust has won a prestigious national award for the work it has done to maximise clinical research activity across the region.
Emirates Stadium, Hornsey Rd, London, N7 7AJ